-
Archives
- June 2018
- February 2018
- May 2017
- January 2017
- December 2016
- November 2016
- October 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- August 2015
- July 2015
- June 2015
- March 2015
- February 2015
- September 2014
- July 2014
- January 2014
- November 2013
- July 2013
- June 2013
- April 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- June 2012
- May 2012
- March 2012
- December 2011
- November 2011
- July 2011
- March 2011
-
Meta
Author Archives: Steffan Stringer
BREXIT: What does it mean for the Life Sciences?
The life sciences industry is critically important to the UK economy: it has a £64 billion turnover and employs more than 233,000 scientists and staff across the UK. It is also one of the most highly regulated and globally harmonised … Continue reading
Comments Off on BREXIT: What does it mean for the Life Sciences?
New Committee Members
At our last managing committee meeting, the AHPPI welcomed the following new committee members. We are very fortunate to have them on the team and look forward to working with them. Dr Muna Albayaty Medical Director, PAREXEL, London Muna is a Consultant … Continue reading
Comments Off on New Committee Members
Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away
Joint Meeting of European Human Pharmacological Societies 17 May – 19 May, 2017, London You still have time to register for the EUFEMED 2017 conference – Exploratory Medicines Development: Innovation And Risk Management. The Faculty of Pharmaceutical Medicine has approved this event … Continue reading
Comments Off on Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – one week away
Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines
ITMAT in Edinburgh Big Data & the Development of New Medicines Friday 17 March 2017, Edinburgh, UK Registration and abstract submission are open for the Institute for Translational Medicine & Therapeutics (ITMAT) in Edinburgh Meeting, which will be held on ‘Big Data & … Continue reading
Comments Off on Abstract and Bursary deadlines 31-Jan-2017: Big Data & the Development of New Medicines
Big Data & the Development of New Medicines
ITMAT in Edinburgh Big Data & the Development of New Medicines Friday 17 March 2017, Edinburgh, UK Registration has begun for the Institute for Translational Medicine & Therapeutics (ITMAT) in Edinburgh Meeting, which will be held on the theme of ‘Big … Continue reading
Comments Off on Big Data & the Development of New Medicines
Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – registration open
Registration for the EUFEMED 2017 conference – Exploratory Medicines Development: Innovation And Risk Management has now opened. Members of AHPPI get substantial savings on the non-member prices ranging from £37 (early-bird workshop only) to £103.20 (early-bird workshop and conference) when including … Continue reading
Comments Off on Exploratory Medicines Development: Innovation And Risk Management, London, May 2017 – registration open
EUFEMED Clinical Pharmacology Conference, London, May 2017 – Web site goes live!
Letter from the President: Dear Colleague, On behalf of the Organising and Scientific Committees it is our great pleasure to welcome you to the 1st conference of the European Federation for Exploratory Medicines Development (EUFEMED), to be held from May 18 – 19, … Continue reading
Comments Off on EUFEMED Clinical Pharmacology Conference, London, May 2017 – Web site goes live!
Revising the guideline on first-in-human clinical trials
The EMA yesterday published a guideline: Draft guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products The document can be found here. The consultation period ends 28-Feb-2017.
Comments Off on Revising the guideline on first-in-human clinical trials
Exploratory medicines development – Innovation and risk management
First EUFEMED Conference Joint Meeting of European Human Pharmacological Societies Wednesday 17 May – Friday 19 May, 2017, London/UK Assessment and mitigation of risk are most challenging in exploratory drug development when a promising new compound is to be characterised … Continue reading
Comments Off on Exploratory medicines development – Innovation and risk management
Safety & Regulation in Early Clinical Drug Development, 02-Dec-2016
The BAPU (Belgian Association of Phase I Units) board is pleased to invite you to the BAPU Symposium: “Safety & Regulation in Early Clinical Drug Development”, which will take place on Friday December 2, 2016 at the Marriot Hotel in Gent. Please find … Continue reading
Comments Off on Safety & Regulation in Early Clinical Drug Development, 02-Dec-2016